General MedicationsINJECTIONGeneric
INNOVAR
DROPERIDOL; FENTANYL CITRATE
Standard Dose
2.5MG/ML;EQ 0.05MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview INNOVAR is listed in Drugs@FDA under application 016049 (NDA).
Marketing status: Discontinued Active ingredient DROPERIDOL; FENTANYL CITRATE Form and strength INJECTABLE;INJECTION - 2.5MG/ML;EQ 0.05MG BASE/ML Sponsor EPIC PHARMA LLC Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview INNOVAR is listed in Drugs@FDA under application 016049 (NDA). Marketing status: Discontinued Active ingredient DROPERIDOL; FENTANYL CITRATE Form and strength INJECTABLE;INJECTION - 2.5MG/ML;EQ 0.05MG BASE/ML Sponsor EPIC PHARMA LLC Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.